Seth Shaffer is an assistant professor of internal medicine in the section of gastroenterology at the University of Manitoba. He is a research scientist at the Children’s Hospital Research Institute of Manitoba and an expert in health economics and inflammatory bowel disease (IBD). His research focuses on improving the delivery of care for patients with IBD by examining healthcare costs, disability and employment outcomes, and treatment efficacy.
Shaffer’s current projects include assessing the indirect costs associated with IBD and evaluating how therapies can reduce disability and unemployment. He is also collaborating with Charles Bernstein to study the impact of the COVID-19 pandemic on IBD care in Manitoba and is establishing a microscopic colitis cohort to improve understanding of the disease. His research findings aim to make healthcare delivery more efficient and cost-effective.
His work extends beyond Manitoba. He is affiliated with the International Research Network on Transitions to Adulthood from Care, the SPOR Evidence Alliance Research Network and the Specialized Services for Children and Youth Research and Evaluation Committee.
Shaffer completed his medical degree and a bachelor of science in medicine at the University of Manitoba. He trained in internal medicine at Queen’s University before returning to Manitoba for a gastroenterology fellowship. He then completed an advanced inflammatory bowel disease fellowship at the University of Chicago, where he also earned a master of science in public health sciences with a focus on health economics. In 2020, he returned to the University of Manitoba as an assistant professor.
His contributions to medical education and research have been recognized with multiple awards, including the Joseph B. Kirsner Fellowship at the University of Chicago in 2019 and the Dean of Medicine’s Education and Research Fellowship Award at the University of Manitoba in 2018. He also received the Resident Leadership Award at Queen’s University in 2015 and 2016.
Shaffer continues to lead research in IBD and health economics while training future specialists and contributing to healthcare improvements for patients with gastrointestinal diseases.